- 专利标题： TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
-
申请号： US17081538申请日： 2020-10-27
-
公开(公告)号： US20210038695A1公开(公告)日： 2021-02-11
- 发明人: Elizabeth L. SANGUINETTI , Thomas B. MARRIOTT , Jennifer LOPANSRI , Consuelo M. BLOSCH
- 申请人： SHIRE-NPS PHARMACEUTICALS, INC.
- 申请人地址： US MA Lexington
- 专利权人： SHIRE-NPS PHARMACEUTICALS, INC.
- 当前专利权人： SHIRE-NPS PHARMACEUTICALS, INC.
- 当前专利权人地址： US MA Lexington
- 主分类号： A61K38/26
- IPC分类号： A61K38/26 ; A61K9/00 ; A61B5/00
摘要：
Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
信息查询
IPC分类:
